Page last updated: 2024-10-27

flecainide and Dilatation, Pathologic

flecainide has been researched along with Dilatation, Pathologic in 2 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eijsbouts, SC1
Houben, RP1
Blaauw, Y1
Schotten, U1
Allessie, MA1
Eckardt, L1
Haverkamp, W1
Göttker, U1
Madeja, M1
Johna, R1
Borggrefe, M1
Breithardt, G1

Other Studies

2 other studies available for flecainide and Dilatation, Pathologic

ArticleYear
Synergistic action of atrial dilation and sodium channel blockade on conduction in rabbit atria.
    Journal of cardiovascular electrophysiology, 2004, Volume: 15, Issue:12

    Topics: Analysis of Variance; Animals; Anisotropy; Anti-Arrhythmia Agents; Dilatation, Pathologic; Electroph

2004
Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart.
    Journal of cardiovascular electrophysiology, 1998, Volume: 9, Issue:4

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dilatation, Pathologic; Electrocardiography; Fle

1998